Pegasystems director granted stock, 7,947 options

PEGASYSTEMS INC (PEGA) reported that Director Peter Gyenes received equity compensation for his annual board term.

Rhea-AI Filing Summary

PEGASYSTEMS INC (PEGA) reported that Director Peter Gyenes received equity compensation for his annual board term. He was granted 3,868 shares of unrestricted common stock and a fully vested non-statutory stock option for 7,947 shares of common stock at an exercise price of $32.32 per share, expiring on 2036-08-15. Following these grants, he directly holds 30,586 shares of common stock.

Insider Trade Summary

Grant/Award: 11,815 shares

Grant/Award 2 txns

Insider GYENES PETER

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options F2	7,947	$0.00	$0.00
Grant/Award	Common stock F1	3,868	$0.00	$0.00

Holdings After Transaction: Stock Options — 7,947 contracts (Direct); Common stock — 30,586 shares (Direct)

Footnotes (2)

1. F1. Represents shares of unrestricted common stock received as consideration for the reporting person's service as a Director for the annual term.
2. F2. Non-statutory stock option fully vested on issuance and granted as consideration for the reporting person's services as a Director for the annual term.

Key Figures

Unrestricted common shares granted: 3,868 shares Options granted (underlying shares): 7,947 shares Option exercise price: $32.32 per share +3 more

6 metrics

Unrestricted common shares granted 3,868 shares Shares of unrestricted common stock received as consideration for service as Director for the annual term

Options granted (underlying shares) 7,947 shares Non-statutory stock option fully vested on issuance for service as Director for the annual term

Option exercise price $32.32 per share Conversion or exercise price of the non-statutory stock option granted on 2026-08-15

Option expiration date 2036-08-15 Expiration date of the non-statutory stock option for 7,947 shares

Common shares held after transaction 30,586 shares Total direct PEGA common stock holdings by Peter Gyenes following the 3,868-share grant

Grant date 2026-08-15 Transaction date for both the unrestricted stock grant and the stock option grant

Key Terms

unrestricted common stock, Non-statutory stock option, fully vested on issuance

3 terms

unrestricted common stock financial

"Represents shares of unrestricted common stock received as consideration"

Non-statutory stock option financial

"Non-statutory stock option fully vested on issuance and granted"

A non-statutory stock option is a company-granted right that lets a person buy shares later at a set price but does not receive special tax-favored treatment under tax law. It matters to investors because when the option is used the holder usually pays ordinary income tax on the gain and the company records compensation cost and issues new shares, which can reduce existing owners’ percentage ownership—think of it like a coupon to buy stock that creates a taxable event and some dilution.

fully vested on issuance financial

"Non-statutory stock option fully vested on issuance and granted"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did PEGA Director Peter Gyenes receive in this Form 4?

Peter Gyenes received 3,868 shares of unrestricted PEGA common stock and a non-statutory stock option for 7,947 shares. Both awards were granted as consideration for his service as a Director for the annual term.

What is the exercise price and term of the new stock options granted to the PEGA director?

The newly granted non-statutory stock options have an exercise price of $32.32 per share and an expiration date of 2036-08-15. The filing states these options were fully vested on issuance as compensation for the director’s annual term.

How many PEGA common shares does Peter Gyenes hold after these transactions?

After the reported equity awards, Peter Gyenes directly holds 30,586 shares of PEGA common stock. This figure reflects the addition of 3,868 unrestricted shares granted as consideration for his service as a Director for the annual term.

Were the PEGA equity awards to Director Peter Gyenes part of regular board compensation?

Yes. The filing states the 3,868 unrestricted shares and the fully vested non-statutory stock option for 7,947 shares were granted as consideration for Peter Gyenes’ services as a Director for the annual term.

Does this PEGA Form 4 indicate any stock sales or dispositions by Peter Gyenes?

No. The Form 4 reports only acquisitions: grants of 3,868 unrestricted shares and options for 7,947 shares. The transaction summary shows acquireCount 2 and disposeCount 0, with no reported sales or other dispositions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/18/2026 - 04:22 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GYENES PETER

(Last) (First) (Middle)

C/O PEGASYSTEMS INC

225 WYMAN STREET, STE 300

(Street)

WALTHAM MASSACHUSETTS 02451

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PEGASYSTEMS INC [ PEGA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	08/15/2026		A		3,868(1)	A	$0	30,586	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$32.32	08/15/2026		A		7,947(2)		08/15/2026	08/15/2036	Common stock	7,947	$0	7,947	D

Explanation of Responses:

1. Represents shares of unrestricted common stock received as consideration for the reporting person's service as a Director for the annual term.

2. Non-statutory stock option fully vested on issuance and granted as consideration for the reporting person's services as a Director for the annual term.

Remarks:

	/s/ Ewelina Kemp, Attorney-in-Fact for Peter Gyenes	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)